Onco-Innovations Limited
ONCO
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.40K | 14.20K | 23.00K | 23.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.40K | 14.20K | 23.00K | 23.00K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 50.40K | 14.20K | 23.00K | 23.00K | -- |
| SG&A Expenses | 2.00M | 398.20K | 916.70K | 916.80K | 97.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.33M | 596.50K | 982.50K | 982.70K | 119.80K |
| Operating Income | -2.28M | -582.30K | -959.60K | -959.70K | -119.80K |
| Income Before Tax | -2.60M | -1.93M | -2.81M | -2.81M | -132.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.60M | -1.93M | -2.81M | -2.81M | -132.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.60M | -1.93M | -2.81M | -2.81M | -132.60K |
| EBIT | -2.28M | -582.30K | -959.60K | -959.70K | -119.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.05 | -0.04 | -0.08 | -0.08 | 0.00 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.03 | -0.03 | 0.00 |
| EPS Diluted | -0.05 | -0.04 | -0.08 | -0.08 | 0.00 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.03 | -0.03 | 0.00 |
| Average Basic Shares Outstanding | 54.33M | 52.50M | 33.91M | 33.91M | 38.39M |
| Average Diluted Shares Outstanding | 54.33M | 52.50M | 33.91M | 33.91M | 38.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |